Bahrain approves Pfizer/BioNTech COVID-19 vaccine use


By ELydf
  • World
  • Saturday, 05 Dec 2020

MANAMA, Dec. 4 (Xinhua) -- Bahrain's health regulator on Friday announced the authorization of emergency use of the Pfizer/BioNTech COVID-19 vaccine.

"Bahrain has approved the emergency use of Pfizer/BioNTech COVID-19 vaccine that will be used for high risk groups," said the National Health Regulatory Authority (NHRA).

It added that the decision follows an intensive study that was conducted based on the results of the vaccine in terms of its safety and effectiveness.

"The approval of the Pfizer/BioNTech vaccine will add a further important layer to the kingdom's national COVID-19 response, which has strongly prioritized protecting the health of all citizens and residents during the pandemic," said CEO of NHRA Mariam Al Jalahma.

For her part, Pfizer Gulf Cluster Lead Lindsey Dietschi, said that the emergency use authorization in Bahrain marks a historic moment in the fight against COVID-19.

"This authorization is a goal we have been working toward since we first declared that science will win," she added.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
   

Next In World

EU leaders turn to gas price caps to end energy crunch
Lesotho votes in election with political crisis still unresolved
Washington-based think tank PIIE projects mild U.S. recession in 2023
IMF chief highlights "fundamental shift" in global economy
U.S. Philadelphia apologizes for experiments on African American inmates
1st LD Writethru: 2 dead, 6 injured in stabbing attack in Las Vegas: police
U.S. stocks fall ahead of key jobs report
Four-member SpaceX crew safely docks with space station
U.S. agricultural futures fall
China overcomes Netherlands in five-set thriller at women's volleyball worlds

Others Also Read